{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:39:23Z","timestamp":1684471163987},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/eye.2012.139","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T10:03:29Z","timestamp":1340964209000},"page":"1036-1038","source":"Crossref","is-referenced-by-count":1,"title":["London 2012: prescribing for athletes in ophthalmology"],"prefix":"10.1038","volume":"26","author":[{"given":"R G H","family":"Nicholson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G P L","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"key":"BFeye2012139_CR1","unstructured":"World Anti-Doping Agency. The 2012 Prohibited List. \n                    www.wada-ama.org\/Documents\/World_Anti-Doping_Program\/WADP-Prohibited-list\/2012\/WADA_Prohibited_List_2012_EN.pdf\n                    \n                  . (accessed 27 June 2012)."},{"key":"BFeye2012139_CR2","unstructured":"British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary, Issue 63. BMJ Publishing Group: UK, 2012."},{"key":"BFeye2012139_CR3","unstructured":"UK Anti-Doping. The UK Anti-Doping Rules, Version 2.0. 1999. \n                    www.ukad.org.uk\/resources\/document-download\/uk-anti-doping-rules\n                    \n                  . (accessed 27 June 2012)."},{"key":"BFeye2012139_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","volume":"37","author":"A Urtti","year":"1993","unstructured":"Urtti A, Salminen L . Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol 1993; 37: 435\u2013456.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2012139_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/rheumatology\/keh338","volume":"43","author":"R Smith","year":"2004","unstructured":"Smith R, Barnsley L, Kannangara S, Mace A . Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines. Rheumatology 2004; 43: 1473\u20131475.","journal-title":"Rheumatology"},{"key":"BFeye2012139_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2273.2004.00965.x","volume":"30","author":"A Mace","year":"2005","unstructured":"Mace A, Smith R, Sandhu G . How we do it: ENT prescribing to competitive athletes--a review of current regulations. Clin Otolaryngol 2005; 30: 201\u2013205.","journal-title":"Clin Otolaryngol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2012139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:16:23Z","timestamp":1684430183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2012139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFeye2012139"],"URL":"https:\/\/doi.org\/10.1038\/eye.2012.139","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,29]]}}}